Sansure Biotech Inc. (688289.SH): Fully Automated Nucleic Acid Processing System (S-S13E-P/S-S13E-P1) Obtains EU CE-IVDR Certification

Stock News12-11

Sansure Biotech Inc. (688289.SH) announced that its fully automated nucleic acid processing system (S-S13E-P/S-S13E-P1) has recently received EU CE-IVDR certification. The device enables end-to-end automation from sample to report, including tube decapping, pipetting, nucleic acid extraction, PCR setup, sealing, amplification, and result analysis. It features high efficiency, precision, intelligent control, and broad compatibility.

The system supports a wide range of tests, covering HPV, sexually transmitted diseases, bloodborne pathogens, respiratory infections, vector-borne diseases, and pharmacogenomics. It is adaptable to various professional settings such as laboratories, hospitals, and testing centers, efficiently meeting diverse needs for sample testing and experimental analysis within limited space.

This CE-IVDR certification marks a critical step in the company's internationalization and standardization of molecular diagnostic technologies. The milestone not only demonstrates the product's superior performance and safety standards but also reflects the company's commitment to leading industry innovation and serving global markets.

Moving forward, Sansure Biotech will continue to drive technological advancements and integrated solutions, empowering global healthcare institutions and public health systems to build a more efficient, precise, and reliable health protection ecosystem.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1103030901?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-11 18:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103030901","market":"sg","top_or_hot":-1,"title":"Sansure Biotech Inc. (688289.SH): Fully Automated Nucleic Acid Processing System (S-S13E-P/S-S13E-P1) Obtains EU CE-IVDR Certification","media":"Stock News","content":"<p>Sansure Biotech Inc. (688289.SH) announced that its fully automated nucleic acid processing system (S-S13E-P/S-S13E-P1) has recently received EU CE-IVDR certification. The device enables end-to-end automation from sample to report, including tube decapping, pipetting, nucleic acid extraction, PCR setup, sealing, amplification, and result analysis. It features high efficiency, precision, intelligent control, and broad compatibility.</p>\n<p>The system supports a wide range of tests, covering HPV, sexually transmitted diseases, bloodborne pathogens, respiratory infections, vector-borne diseases, and pharmacogenomics. It is adaptable to various professional settings such as laboratories, hospitals, and testing centers, efficiently meeting diverse needs for sample testing and experimental analysis within limited space.</p>\n<p>This CE-IVDR certification marks a critical step in the company's internationalization and standardization of molecular diagnostic technologies. The milestone not only demonstrates the product's superior performance and safety standards but also reflects the company's commitment to leading industry innovation and serving global markets.</p>\n<p>Moving forward, Sansure Biotech will continue to drive technological advancements and integrated solutions, empowering global healthcare institutions and public health systems to build a more efficient, precise, and reliable health protection ecosystem.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sansure Biotech Inc. (688289.SH): Fully Automated Nucleic Acid Processing System (S-S13E-P/S-S13E-P1) Obtains EU CE-IVDR Certification</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSansure Biotech Inc. (688289.SH): Fully Automated Nucleic Acid Processing System (S-S13E-P/S-S13E-P1) Obtains EU CE-IVDR Certification\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-11 18:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sansure Biotech Inc. (688289.SH) announced that its fully automated nucleic acid processing system (S-S13E-P/S-S13E-P1) has recently received EU CE-IVDR certification. The device enables end-to-end automation from sample to report, including tube decapping, pipetting, nucleic acid extraction, PCR setup, sealing, amplification, and result analysis. It features high efficiency, precision, intelligent control, and broad compatibility.</p>\n<p>The system supports a wide range of tests, covering HPV, sexually transmitted diseases, bloodborne pathogens, respiratory infections, vector-borne diseases, and pharmacogenomics. It is adaptable to various professional settings such as laboratories, hospitals, and testing centers, efficiently meeting diverse needs for sample testing and experimental analysis within limited space.</p>\n<p>This CE-IVDR certification marks a critical step in the company's internationalization and standardization of molecular diagnostic technologies. The milestone not only demonstrates the product's superior performance and safety standards but also reflects the company's commitment to leading industry innovation and serving global markets.</p>\n<p>Moving forward, Sansure Biotech will continue to drive technological advancements and integrated solutions, empowering global healthcare institutions and public health systems to build a more efficient, precise, and reliable health protection ecosystem.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_FSXE","symbol_name":"微型欧盟50指数","start_time":0,"source_url":"","article_id":"1103030901","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103030901","pubTimestamp":1765449886,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Sansure Biotech Inc. (688289.SH) announced that its fully automated nucleic acid processing system (S-S13E-P/S-S13E-P1) has recently received EU CE-IVDR certification. The device enables end-to-end...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688289":"圣湘生物","BK4109":"特种化学制品","BK0239":"医药制造","BK4588":"碎股","BK4585":"ETF&股票定投概念","CE":"塞拉尼斯"},"translate_title":"三保生物（688289.SH）：全自动核酸处理系统（S-S13E-P/S-S13E-P1）获得欧盟CE-IVDR认证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688289":1,"CE":1,"FESXmain":1,"FSXEmain":1},"content_text":"Sansure Biotech Inc. (688289.SH) announced that its fully automated nucleic acid processing system (S-S13E-P/S-S13E-P1) has recently received EU CE-IVDR certification. The device enables end-to-end automation from sample to report, including tube decapping, pipetting, nucleic acid extraction, PCR setup, sealing, amplification, and result analysis. It features high efficiency, precision, intelligent control, and broad compatibility.\nThe system supports a wide range of tests, covering HPV, sexually transmitted diseases, bloodborne pathogens, respiratory infections, vector-borne diseases, and pharmacogenomics. It is adaptable to various professional settings such as laboratories, hospitals, and testing centers, efficiently meeting diverse needs for sample testing and experimental analysis within limited space.\nThis CE-IVDR certification marks a critical step in the company's internationalization and standardization of molecular diagnostic technologies. The milestone not only demonstrates the product's superior performance and safety standards but also reflects the company's commitment to leading industry innovation and serving global markets.\nMoving forward, Sansure Biotech will continue to drive technological advancements and integrated solutions, empowering global healthcare institutions and public health systems to build a more efficient, precise, and reliable health protection ecosystem.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1103030901","isCrawlerRequest":true}